澳大利亚昆士兰州儿童流感疫苗资助计划首年四价疫苗效果评估
2018年昆士兰州为6月龄至<5岁儿童资助四价灭活流感疫苗,采用匹配病例对照研究分析1125例病例和10645名对照。调整后疫苗总体有效性为51%(95%CI 41-60),两剂次接种和完整接种程序的有效性均为60%。
要点
- 资助计划首年儿童四价流感疫苗总体有效性为51%(95%CI 41-60)。
- 完成两剂次接种或完整接种程序的儿童疫苗有效性均为60%。
- 疫苗有效性随年龄增长而增加,应遵循国家首季两剂次接种程序。
核心结论
- 2018年昆士兰州资助儿童流感疫苗计划首年观察到中等疫苗有效性,支持儿童流感疫苗接种。
研究设计与样本
- 匹配病例对照研究,病例来自昆士兰州2018年流感通报数据中符合资助接种年龄的儿童,对照来自澳大利亚免疫登记册中昆士兰居民同龄儿童,每例最多匹配10名对照,匹配地点和出生日期。
主要发现
- 共分析1125例病例和10645名匹配对照。
- 针对实验室确诊流感的调整后总体疫苗有效性为51%(95%CI 41-60)。
- 2018年接种两剂次儿童的调整后疫苗有效性为60%(95%CI 46-70)。
- 按国家推荐完成接种程序(首季两剂次)儿童的调整后疫苗有效性为60%(95%CI 48-69)。
- 疫苗有效性随年龄增长而增加。
关键数值与推荐
- 首剂疫苗接种在标本采集前≥14天视为有效。
- 第二剂次在首剂接种后≥28天接种视为有效。
- 疫苗有效性针对实验室确诊流感,调整了性别和原住民身份。
临床怎么用
- 儿童流感疫苗接种应遵循国家首季两剂次程序以确保最大保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following high influenza activity in 2017, the state of Queensland, Australia, funded a quadrivalent inactivated influenza vaccination program for children aged 6 months to <5 years in 2018. We calculated influenza vaccine effectiveness (VE) among children eligible for this program. METHODS: A matched case-control study was conducted. Cases were identified using Queensland 2018 influenza notification data among children age-eligible for funded vaccination. Controls were drawn from Australian Immunisation Register records of Queensland resident children age-eligible for funded influenza vaccine. Up to 10 controls per case were matched for location and birthdate. First dose vaccination was valid if received ≥14 days prior to specimen collection; a second dose was valid if received ≥28 days after first dose receipt. VE was calculated for vaccine doses and adherence to national recommendations for two doses in the first season (schedule completeness) and adjusted (VEadj) for sex and First Nations status. RESULTS: There were 1,125 cases and 10,645 matched controls analysed. Overall VEadj against laboratory-confirmed influenza was 51% (95% confidence interval (CI) 41-60). VEadj was 60% (95% CI 46-70) for children who received two doses in 2018, and 60% (95% CI 48-69) for children vaccinated appropriately according to schedule completeness. VE increased with age. CONCLUSIONS: Moderate vaccine effectiveness was observed for children eligible for the funded program in Queensland in 2018, adding to the sparse evidence for influenza vaccine use in Australian children. Adhering to the national first season two dose schedule for influenza vaccine receipt in children ensures maximum protection.
引用
- Thangarajah D, Malo JA, Field E, et al. Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018. Vaccine. 2020. PMID: 33358414. doi:10.1016/j.vaccine.2020.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。